Chemoinformaics analysis of 8-Demethylsideroxylin
| Molecular Weight | 298.294 | nRot | 2 |
| Heavy Atom Molecular Weight | 284.182 | nRig | 18 |
| Exact Molecular Weight | 298.084 | nRing | 3 |
| Solubility: LogS | -3.739 | nHRing | 1 |
| Solubility: LogP | 3.8 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 36 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 2 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 17 |
| nHA | 5 | APOL | 41.7351 |
| nHD | 2 | BPOL | 18.3849 |
| QED | 0.759 |
| Synth | 2.293 |
| Natural Product Likeliness | 1.263 |
| NR-PPAR-gamma | 0.948 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.005 |
| Pgp-sub | 0.988 |
| HIA | 0.011 |
| CACO-2 | -4.796 |
| MDCK | 0.0000135 |
| BBB | 0.01 |
| PPB | 0.975649 |
| VDSS | 0.488 |
| FU | 0.0416608 |
| CYP1A2-inh | 0.936 |
| CYP1A2-sub | 0.94 |
| CYP2c19-inh | 0.771 |
| CYP2c19-sub | 0.072 |
| CYP2c9-inh | 0.687 |
| CYP2c9-sub | 0.903 |
| CYP2d6-inh | 0.528 |
| CYP2d6-sub | 0.867 |
| CYP3a4-inh | 0.494 |
| CYP3a4-sub | 0.219 |
| CL | 5.529 |
| T12 | 0.634 |
| hERG | 0.047 |
| Ames | 0.389 |
| ROA | 0.09 |
| SkinSen | 0.855 |
| Carcinogencity | 0.279 |
| EI | 0.915 |
| Respiratory | 0.27 |
| NR-Aromatase | 0.891 |
| Antiviral | Yes |
| Prediction | 0.792037 |